This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
blockchain: Archive
Is ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for REGL
REGLNegative Net Change WSMNegative Net Change MDUNegative Net Change VIGPositive Net Change DGRONegative Net Change RRXNegative Net Change
bitcoin blockchain dividend etf expenses holdings index
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
FYCPositive Net Change ARRYPositive Net Change IWOPositive Net Change GBTPositive Net Change VBKPositive Net Change CELHNegative Net Change
bitcoin blockchain dividend etf expenses holdings index market-capitalization
3 Reasons Growth Investors Will Love Flowers Foods (FLO)
by Zacks Equity Research
Flowers Foods (FLO) could produce exceptional returns because of its solid growth attributes.
FLONegative Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy SQM (SQM) Now
by Zacks Equity Research
SQM (SQM) is well positioned to outperform the market, as it exhibits above-average growth in financials.
SQMNegative Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
Mid-America Apartment Communities (MAA) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Mid-America Apartment Communities (MAA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
MAANegative Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why The ONE Group Hospitality, Inc. (STKS) is a Solid Choice
by Zacks Equity Research
The ONE Group Hospitality, Inc. (STKS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
STKSNegative Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why Arkema SA (ARKAY) is a Solid Choice
by Zacks Equity Research
Arkema SA (ARKAY) possesses solid growth attributes, which could help it handily outperform the market.
ARKAYPositive Net Change
blockchain earnings-growth growth-investing growth-investors growth-stocks
A10 Networks (ATEN) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
A10 Networks (ATEN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ATENPositive Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
NextCure, Inc. (NXTC) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
NextCure, Inc. (NXTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
NXTCPositive Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes SFL Corporation (SFL) a New Strong Buy Stock
by Zacks Equity Research
SFL Corporation (SFL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SFLNegative Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why
by Zacks Equity Research
Erytech Pharma SA Sponsored ADR (ERYP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ERYPNegative Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Armada Hoffler Properties (AHH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Armada Hoffler Properties (AHH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AHHNegative Net Change
blockchain earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Wall Street Analysts Think Paypal (PYPL) Could Surge 43%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 43.4% upside potential for Paypal (PYPL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PYPLPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Hello Group Inc. Sponsored ADR (MOMO) Could Surge 115%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Hello Group Inc. Sponsored ADR (MOMO) points to an 115.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
MOMOPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Protagonist Therapeutics (PTGX) Have the Potential to Rally 322% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 322.3% in Protagonist Therapeutics (PTGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
PTGXNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 32% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 31.6% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
KIDSNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 28% Upside in Sierra Bancorp (BSRR): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.2% in Sierra Bancorp (BSRR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
BSRRNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Sutro Biopharma, Inc. (STRO) Have the Potential to Rally 293% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 293.4% in Sutro Biopharma, Inc. (STRO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
STRONegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Golden Entertainment (GDEN) Have the Potential to Rally 55% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 54.6% in Golden Entertainment (GDEN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
GDENPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Inspire (INSP) Could Rally 46%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 46.4% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
INSPNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Can TotalEnergies SE Sponsored ADR (TTE) Climb 32% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for TotalEnergies SE Sponsored ADR (TTE) points to a 32.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
TTEPositive Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Alphatec (ATEC) Could Rally 77%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Alphatec (ATEC) points to a 76.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ATECNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe The ONE Group Hospitality, Inc. (STKS) Could Rally 129%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for The ONE Group Hospitality, Inc. (STKS) points to a 128.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
STKSNegative Net Change
blockchain earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Here's Why TreeHouse Foods (THS) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
THSNegative Net Change
bitcoin blockchain momentum-investor momentum-stocks top-ranked
Albemarle (ALB) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
ALBNegative Net Change
blockchain daily-movers moving-average-crossover stocks-moving-today